Biomarker measurement in non-invasively sampled colorectal mucus as a novel approach to colorectal cancer detection: screening and triage implications
Open Access
- 13 May 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 123 (2), 252-260
- https://doi.org/10.1038/s41416-020-0893-8
Abstract
Background Faecal tests are widely applied for colorectal cancer (CRC) screening and considered for triaging symptomatic patients with suspected CRC. However, faecal tests can be inconvenient, complex and expensive. Colorectal mucus (CM) sampled using our new patient-friendly non-invasive technique is rich in CRC biomarkers. This study aimed to evaluate diagnostic accuracy of CRC detection by measuring protein biomarkers in CM. Methods Colorectal mucus samples were provided by 35 healthy controls, 62 CRC-free symptomatic patients and 40 CRC patients. Biomarkers were quantified by ELISA. Diagnostic performances of haemoglobin, C-reactive protein, tissue inhibitor of metalloproteinases-1, M2-pyruvate kinase, matrix metalloproteinase-9, peptidyl arginine deiminase-4, epidermal growth factor receptor, calprotectin and eosinophil-derived neurotoxin were assessed using receiver operating characteristic (ROC) curve analysis. Results Colorectal mucus haemoglobin was superior compared to other biomarkers. For haemoglobin, the areas under the curve for discriminating between CRC and healthy groups (‘screening’) and between CRC and symptomatic patients (‘triage’) were 0.921 and 0.854 respectively. The sensitivity of 80.0% and specificities of 94.3% and 85.5% for the two settings respectively were obtained. Conclusions Haemoglobin quantification in CM reliably detects CRC. This patient-friendly approach presents an attractive alternative to faecal immunochemical test; however, the two methods need to be directly compared in larger studies.Keywords
Funding Information
- Innovate UK (132672)
This publication has 49 references indexed in Scilit:
- Multitarget Stool DNA Testing for Colorectal-Cancer ScreeningThe New England Journal of Medicine, 2014
- Sample size estimation in diagnostic test studies of biomedical informaticsJournal of Biomedical Informatics, 2014
- Superior diagnostic performance of faecal immunochemical tests for haemoglobin in a head-to-head comparison with guaiac based faecal occult blood test among 2235 participants of screening colonoscopyEuropean Journal of Cancer, 2013
- Clinical Performance of an Automated Stool DNA Assay for Detection of Colorectal NeoplasiaClinical Gastroenterology and Hepatology, 2013
- Next-Generation Stool DNA Test Accurately Detects Colorectal Cancer and Large AdenomasGastroenterology, 2012
- Molecular Detection of Colorectal NeoplasiaGastroenterology, 2010
- Improved Diagnosis of Colorectal Cancer Using a Combination of Fecal Occult Blood and Novel Fecal Protein MarkersClinical Gastroenterology and Hepatology, 2008
- Sensitivity and specificity of faecal tumour M2 pyruvate kinase for detection of colorectal adenomas in a large screening studyBritish Journal of Cancer, 2008
- Cell exfoliation in the human colon: Myth, reality and implications for colorectal cancer screeningInternational Journal of Cancer, 2007
- Localization of tissue inhibitor of metalloproteinases 1 (TIMP‐1) in human colorectal adenoma and adenocarcinomaInternational Journal of Cancer, 2004